{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T14:05:43Z","timestamp":1794837943138,"version":"4.9.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"crossref","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Instituto Nacional de Pesquisa em Resist\u00eancia Antimicrobiana","award":["CNPq 465718\/2014\u20130, FAPERGS 17\/2551\u20130000514-7"],"award-info":[{"award-number":["CNPq 465718\/2014\u20130, FAPERGS 17\/2551\u20130000514-7"]}]},{"DOI":"10.13039\/501100006181","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado da Bahia","doi-asserted-by":"crossref","award":["PP-SUS0014\/2018"],"award-info":[{"award-number":["PP-SUS0014\/2018"]}],"id":[{"id":"10.13039\/501100006181","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Brazilian National Council for Scientific and Technological Development","award":["309564\/2022-0"],"award-info":[{"award-number":["309564\/2022-0"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11115-x","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T09:48:43Z","timestamp":1747820923000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Carbapenem-resistant Enterobacterales bloodstream infections related to death in two Brazilian tertiary hospitals"],"prefix":"10.1186","volume":"25","author":[{"given":"Lorena Galv\u00e3o","family":"de Araujo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kehvyn","family":"Cede\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriele Pinheiro","family":"Bomfim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio","family":"de Oliveira Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Verena","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Goreth","family":"Barberino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edilane Lins","family":"Gouveia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabianna M\u00e1rcia M.","family":"Bahia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitermayer Galv\u00e3o","family":"dos Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joice Neves","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"key":"11115_CR1","doi-asserted-by":"crossref","unstructured":"Trecarichi EM, Tumbarello M. Therapeutic options for carbapenem-resistant Enterobacteriaceae infections. Virulence [Internet]. 2017 [cited 2023 Sep 20];8:470\u201384. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28276996\/","DOI":"10.1080\/21505594.2017.1292196"},{"key":"11115_CR2","doi-asserted-by":"crossref","unstructured":"Sampaio JLM, Gales AC. Antimicrobial resistance in Enterobacteriaceae in Brazil: focus on \u03b2-lactams and polymyxins. Brazilian Journal of Microbiology [Internet]. 2016 [cited 2023 Sep 20];47:31. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5156504\/","DOI":"10.1016\/j.bjm.2016.10.002"},{"key":"11115_CR3","doi-asserted-by":"crossref","unstructured":"Monteiro J, Santos AF, Asensi MD, Peirano G, Gales AC. First Report of KPC-2-Producing Klebsiella pneumoniae Strains in Brazil. Antimicrob Agents Chemother [Internet]. 2009 [cited 2023 Sep 20];53:333. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC2612176\/","DOI":"10.1128\/AAC.00736-08"},{"key":"11115_CR4","doi-asserted-by":"crossref","unstructured":"Bartolleti F, Seco BMS, Dos Santos CC, Felipe CB, Lemo MEB, Alves TDS et al. Polymyxin B Resistance in Carbapenem-Resistant Klebsiella pneumoniae, S\u00e3o Paulo, Brazil. Emerg Infect Dis [Internet]. 2016 [cited 2023 Sep 20];22:1849. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5038415\/","DOI":"10.3201\/eid2210.160695"},{"key":"11115_CR5","doi-asserted-by":"crossref","unstructured":"Kiffer CRV, Rezende TFT, Costa-Nobre DT, Marinonio ASS, Shiguenaga LH, Kulek DNO et al. A 7-Year Brazilian National Perspective on Plasmid-Mediated Carbapenem Resistance in Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii Complex and the Impact of the Coronavirus Disease 2019 Pandemic on Their Occurrence. Clin Infect Dis [Internet]. 2023 [cited 2024 Sep 22];77:S29\u201337. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10321697\/","DOI":"10.1093\/cid\/ciad260"},{"key":"11115_CR6","doi-asserted-by":"crossref","unstructured":"Bianchini ML, Jeffres MN, Campbell JD. Cost-Effectiveness Analysis of New Beta-Lactam Beta-Lactamase Inhibitor Antibiotics Versus Colistin for the Treatment of Carbapenem-Resistant Infections. Hosp Pharm [Internet]. 2020 [cited 2025 Mar 20];57:93. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9065533\/","DOI":"10.1177\/0018578720985436"},{"key":"11115_CR7","doi-asserted-by":"publisher","unstructured":"Concei\u00e7\u00e3o-Neto OC, da Costa BS, Pontes Lda, Silveira S, Justo-da-Silva MC, de Oliveira Santos LH et al. IC,. Polymyxin Resistance in Clinical Isolates of K. pneumoniae in Brazil: Update on Molecular Mechanisms, Clonal Dissemination and Relationship With KPC-Producing Strains. Front Cell Infect Microbiol [Internet]. 2022 [cited 2023 Sep 20];12. Available from: https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fcimb.2022.898125\/full","DOI":"10.3389\/fcimb.2022.898125\/full"},{"key":"11115_CR8","doi-asserted-by":"crossref","unstructured":"Mohapatra SS, Dwibedy SK, Padhy I. Polymyxins, the last-resort antibiotics: Mode of action, resistance emergence, and potential solutions. J Biosci [Internet]. 2021 [cited 2024 Sep 22];46. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34475315\/","DOI":"10.1007\/s12038-021-00209-8"},{"key":"11115_CR9","doi-asserted-by":"crossref","unstructured":"Yang S, Wang H, Zhao D, Zhang S, Hu C. Polymyxins: recent advances and challenges. Front Pharmacol [Internet]. 2024 [cited 2024 Sep 22];15. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11224486\/","DOI":"10.3389\/fphar.2024.1424765"},{"key":"11115_CR10","doi-asserted-by":"crossref","unstructured":"Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, Van Duin D, Clancy CJ. Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum \u03b2-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa). Clin Infect Dis [Internet]. 2021 [cited 2023 Sep 21];72:1109\u201316. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33830222\/","DOI":"10.1093\/cid\/ciab295"},{"key":"11115_CR11","doi-asserted-by":"crossref","unstructured":"McConville TH, Sullivan SB, Gomez-Simmonds A, Whittier S, Uhlemann A-C. Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study. PLoS One [Internet]. 2017 [cited 2023 Sep 21];12:e0186195. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5638409\/","DOI":"10.1371\/journal.pone.0186195"},{"key":"11115_CR12","doi-asserted-by":"publisher","unstructured":"Wang X, Wang Q, Cao B, Sun S, Zhang Y, Gu B et al. Retrospective Observational Study from a Chinese Network of the Impact of Combination Therapy versus Monotherapy on Mortality from Carbapenem-Resistant\u2009<\u2009i\u2009>\u2009Enterobacteriaceae\u2009<\u2009i\u2009>\u2009Bacteremia. Antimicrob Agents Chemother [Internet]. 2019 [cited 2023 Sep 21];63. Available from: https:\/\/doi.org\/10.1128\/aac.01511-18","DOI":"10.1128\/aac.01511-18"},{"key":"11115_CR13","unstructured":"2019 [Internet]. CDC. Antibiotic resistance threats in the United States, Atlanta G. 2019 Nov. Available from: https:\/\/www.cdc.gov\/drugresistance\/pdf\/threats-report\/2019-ar-threats-report-508.pdf"},{"key":"11115_CR14","doi-asserted-by":"crossref","unstructured":"Castanheira M, Deshpande LM, Mendes RE, Canton R, Sader HS, Jones RN. Variations in the Occurrence of Resistance Phenotypes and Carbapenemase Genes Among Enterobacteriaceae Isolates in 20 Years of the SENTRY Antimicrobial Surveillance Program. Open Forum Infect Dis [Internet]. 2019 [cited 2023 Sep 20];6:S23\u201333. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30895212\/","DOI":"10.1093\/ofid\/ofy347"},{"key":"11115_CR15","unstructured":"CDC, National Healthcare Safety Network (NHSN). Bloodstream Infection Event (Central Line-Associated Bloodstream Infection and Non-central Line Associated Bloodstream Infection). 2025 Patient Safety Component Manual [Internet]. 2025 [cited 2025 Mar 18]. pp. 1\u201346. Available from: https:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/pcsmanual_current.pdf"},{"key":"11115_CR16","unstructured":"National Center for Emerging and Zoonotic Infectious Diseases (U.S.), Division of Healthcare Quality Promotion. Facility guidance for control of Carbapenem-resistant Enterobacteriaceae (CRE): November 2015 update - CRE toolkit [Internet]. 2015 [cited 2018 Oct 27]. Available from: www.cdc.gov\/hai\/pdfs\/cre\/CRE-guidance-508.pdf"},{"key":"11115_CR17","doi-asserted-by":"crossref","unstructured":"Barberino MG, Silva M, de O, Arraes ACP, Correia LC, Mendes AV. Direct identification from positive blood broth culture by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry (MALDI-TOF MS). The Brazilian Journal of Infectious Diseases [Internet]. 2017 [cited 2023 Sep 21];21:339\u201342. Available from: https:\/\/www.scielo.br\/j\/bjid\/a\/crdNpQdhhCBsmvhtYq6Jzmn\/?lang=en","DOI":"10.1016\/j.bjid.2017.03.007"},{"key":"11115_CR18","unstructured":"CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 33rd ed. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute. (2023)."},{"key":"11115_CR19","doi-asserted-by":"publisher","unstructured":"Ruxton GD, Neuh\u00e4user M. Review of alternative approaches to calculation of a confidence interval for the odds ratio of a 2 \u00d7 2 contingency table. Methods Ecol Evol [Internet]. 2013 [cited 2023 Aug 22];4:9\u201313. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/https:\/\/doi.org\/10.1111\/j.2041-210x.2012.00250.x","DOI":"10.1111\/j.2041-210x.2012.00250.x"},{"key":"11115_CR20","doi-asserted-by":"publisher","unstructured":"Li X, Ye H. Clinical and Mortality Risk Factors in Bloodstream Infections with Carbapenem-Resistant Enterobacteriaceae. Can J Infect Dis Med Microbiol. 2017;2017:6212910. https:\/\/doi.org\/10.1155\/2017\/6212910. Epub 2017 Dec 12. PMID: 29379527; PMCID: PMC5742906.","DOI":"10.1155\/2017\/6212910"},{"key":"11115_CR21","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2147\/IDR.S294282","volume":"14","author":"C Zhou","year":"2021","unstructured":"Zhou C, Jin L, Wang Q, Wang X, Chen F, Gao Y, Zhao C, Chen H, Cao B, Wang H. Bloodstream infections caused by Carbapenem-Resistant Enterobacterales: risk factors for mortality, antimicrobial therapy and treatment outcomes from a prospective multicenter study. Infect Drug Resist. 2021;14:731\u201342. https:\/\/doi.org\/10.2147\/IDR.S294282. PMID: 33658810; PMCID: PMC7917342.","journal-title":"Infect Drug Resist"},{"issue":"5","key":"11115_CR22","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.3390\/microorganisms11051121","volume":"11","author":"JY Ahn","year":"2023","unstructured":"Ahn JY, Ahn SM, Kim JH, Jeong SJ, Ku NS, Choi JY, Yeom JS, Song JE. Clinical characteristics and associated factors for mortality in patients with Carbapenem-Resistant Enterobacteriaceae bloodstream infection. Microorganisms. 2023;11(5):1121. https:\/\/doi.org\/10.3390\/microorganisms11051121. PMID: 37317095; PMCID: PMC10220897.","journal-title":"Microorganisms"},{"issue":"1","key":"11115_CR23","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/TP.0000000000004265","volume":"107","author":"JA Anesi","year":"2023","unstructured":"Anesi JA, Lautenbach E, Thom KA, Tamma PD, Blumberg EA, Alby K, Bilker WB, Werzen A, Ammazzalorso A, Tolomeo P, Omorogbe J, Pineles L, Han JH. Clinical outcomes and risk factors for Carbapenem-resistant enterobacterales bloodstream infection in solid organ transplant recipients. Transplantation. 2023;107(1):254\u201363. Epub 2022 Dec 8. PMID: 35856636; PMCID: PMC9772065.","journal-title":"Transplantation"},{"issue":"9","key":"11115_CR24","doi-asserted-by":"publisher","first-page":"e0069821","DOI":"10.1128\/AAC.00698-21","volume":"65","author":"L Chen","year":"2021","unstructured":"Chen L, Han X, Li Y, Li M. Assessment of Mortality-Related risk factors and effective antimicrobial regimens for treatment of bloodstream infections caused by Carbapenem-Resistant Enterobacterales. Antimicrob Agents Chemother. 2021;65(9):e0069821. https:\/\/doi.org\/10.1128\/AAC.00698-21. Epub 2021 Aug 17. PMID: 34228539; PMCID: PMC8370219.","journal-title":"Antimicrob Agents Chemother"},{"key":"11115_CR25","doi-asserted-by":"publisher","first-page":"120","DOI":"10.33393\/dti.2023.2622","volume":"17","author":"A So-Ngern","year":"2023","unstructured":"So-Ngern A, Osaithai N, Meesing A, Chumpangern W. Mortality rate and factors associated with mortality of carbapenem-resistant Enterobacteriaceae infection. Drug Target Insights. 2023;17:120\u20135. https:\/\/doi.org\/10.33393\/dti.2023.2622. PMID: 38028024; PMCID: PMC10630699.","journal-title":"Drug Target Insights"},{"issue":"6","key":"11115_CR26","doi-asserted-by":"publisher","first-page":"e13855","DOI":"10.1111\/cts.13855","volume":"17","author":"P Karnmueng","year":"2024","unstructured":"Karnmueng P, Montakantikul P, Paiboonvong T, Plongla R, Chatsuwan T, Chumnumwat S. Mortality factors and antibiotic options in carbapenem-resistant enterobacterales bloodstream infections: insights from a high-prevalence setting with co-occurring NDM-1 and OXA-48. Clin Transl Sci. 2024;17(6):e13855. https:\/\/doi.org\/10.1111\/cts.13855. PMID: 38853376; PMCID: PMC11163016.","journal-title":"Clin Transl Sci"},{"key":"11115_CR27","unstructured":"Tumbarello M, Trecarichi EM, De Rosa FG, Giannella M, Giacobbe DR, Bassetti M et al. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. Journal of Antimicrobial Chemotherapy [Internet]. 2015 [cited 2024 Oct 15];70:2133\u201343. Available from: https:\/\/academic.oup.com\/jac\/article\/70\/7\/2133\/778512?login=false"},{"key":"11115_CR28","doi-asserted-by":"crossref","unstructured":"Anderson DJ, Moehring RW, Sloane R, Schmader KE, Weber DJ, Fowler VG et al. Bloodstream infections in community hospitals in the 21st century: a multicenter cohort study. PLoS One [Internet]. 2014 [cited 2024 Sep 22];9. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24643200\/","DOI":"10.1371\/journal.pone.0091713"},{"key":"11115_CR29","doi-asserted-by":"crossref","unstructured":"Villegas MV, Pallares CJ, Escand\u00f3n-Vargas K, Hern\u00e1ndez-G\u00f3mez C, Correa A, \u00c1lvarez C et al. Characterization and Clinical Impact of Bloodstream Infection Caused by Carbapenemase-Producing Enterobacteriaceae in Seven Latin American Countries. PLoS One [Internet]. 2016 [cited 2024 Sep 22];11. Available from: https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0154092","DOI":"10.1371\/journal.pone.0154092"},{"key":"11115_CR30","doi-asserted-by":"crossref","unstructured":"Chandroulis I, Schinas G, de Lastic AL, Polyzou E, Tsoupra S, Davoulos C et al. Patterns, Outcomes and Economic Burden of Primary vs. Secondary Bloodstream Infections: A Single Center, Cross-Sectional Study. Pathogens [Internet]. 2024 [cited 2025 Mar 22];13. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11357390\/","DOI":"10.3390\/pathogens13080677"},{"key":"11115_CR31","doi-asserted-by":"publisher","unstructured":"Leal HF, Azevedo J, Silva GEO, Amorim AML, de Roma LRC, Arraes ACP et al. Bloodstream infections caused by multidrug-resistant gram-negative bacteria: epidemiological, clinical and microbiological features. BMC Infect Dis [Internet]. 2019 [cited 2023 Jul 9];19:609. Available from: https:\/\/bmcinfectdis.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s12879-019-4265-z","DOI":"10.1186\/s12879-019-4265-z"},{"key":"11115_CR32","doi-asserted-by":"crossref","unstructured":"Sante L, Aguirre-Jaime A, Miguel MA, Ramos MJ, Pedroso Y, Lecuona M. Epidemiological study of secondary bloodstream infections: The forgotten issue. J Infect Public Health [Internet]. 2019 [cited 2025 Mar 22];12:37\u201342. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1876034118301400?via%3Dihub","DOI":"10.1016\/j.jiph.2018.08.011"},{"key":"11115_CR33","doi-asserted-by":"crossref","unstructured":"Haimerl BJ, Encinas R, Justo JA, Kohn J, Bookstaver PB, Winders HR et al. Optimization of Empirical Antimicrobial Therapy in Enterobacterales Bloodstream Infection Using the Extended-Spectrum Beta-Lactamase Prediction Score. Antibiotics (Basel) [Internet]. 2023 [cited 2024 Sep 22];12. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37370322\/","DOI":"10.3390\/antibiotics12061003"},{"key":"11115_CR34","doi-asserted-by":"crossref","unstructured":"Pospi\u0161il M, Car H, Elve\u0111i-Ga\u0161parovi\u0107 V, Beader N, Herljevi\u0107 Z, Bedeni\u0107 B. Bloodstream Infections by AmpC-Producing Enterobacterales: Risk Factors and Therapeutic Outcome. Pathogens [Internet]. 2023 [cited 2024 Sep 22];12. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37764933\/","DOI":"10.3390\/pathogens12091125"},{"key":"11115_CR35","doi-asserted-by":"crossref","unstructured":"Zhou C, Jin L, Wang Q, Wang X, Chen F, Gao Y et al. Bloodstream Infections Caused by Carbapenem-Resistant Enterobacterales: Risk Factors for Mortality, Antimicrobial Therapy and Treatment Outcomes from a Prospective Multicenter Study. Infect Drug Resist [Internet]. 2021 [cited 2024 Oct 15];14:731. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7917342\/","DOI":"10.2147\/IDR.S294282"},{"key":"11115_CR36","doi-asserted-by":"crossref","unstructured":"Li C, Li Y, Zhao Z, Liu Q, Li B. Treatment options and clinical outcomes for carbapenem-resistant Enterobacteriaceae bloodstream infection in a Chinese university hospital. J Infect Public Health [Internet]. 2019 [cited 2024 Oct 15];12:26\u201331. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1876034118301175?via%3Dihub","DOI":"10.1016\/j.jiph.2018.08.002"},{"issue":"5","key":"11115_CR37","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.4269\/ajtmh.22-0556","volume":"109","author":"F Krapp","year":"2023","unstructured":"Krapp F, Garc\u00eda C, Hinostroza N, Astocondor L, Rondon CR, Ingelbeen B, et al. Prevalence of antimicrobial resistance in Gram-Negative Bacteria bloodstream infections in Peru and associated outcomes: VIRAPERU study. Am J Trop Med Hyg. 2023;109(5):1095\u2013106. https:\/\/doi.org\/10.4269\/ajtmh.22-0556. PMID: 37722663; PMCID: PMC10622474.","journal-title":"Am J Trop Med Hyg"},{"key":"11115_CR38","doi-asserted-by":"crossref","unstructured":"Amanati A, Sajedianfard S, Khajeh S, Ghasempour S, Mehrangiz S, Nematolahi S et al. Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multidrug resistance. BMC Infect Dis [Internet]. 2021 [cited 2024 Oct 15];21. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8254331\/","DOI":"10.1186\/s12879-021-06243-z"},{"key":"11115_CR39","doi-asserted-by":"crossref","unstructured":"Rossi F, Girardello R, Cury AP, Di Gioia TSR, de Almeida JN. Duarte AJ da S. Emergence of colistin resistance in the largest university hospital complex of S\u00e3o Paulo, Brazil, over five years. Braz J Infect Dis [Internet]. 2017 [cited 2024 Oct 15];21:98\u2013101. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1413867016304421?via%3Dihub","DOI":"10.1016\/j.bjid.2016.09.011"},{"key":"11115_CR40","doi-asserted-by":"crossref","unstructured":"Pereira PS, De araujo CFM, Seki LM, Zahner V, Carvalho-Assef APDA, Asensi MD. Update of the molecular epidemiology of KPC-2-producing Klebsiella pneumoniae in Brazil: spread of clonal complex 11 (ST11, ST437 and ST340). J Antimicrob Chemother [Internet]. 2013 [cited 2024 Sep 22];68:312\u20136. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23070735\/","DOI":"10.1093\/jac\/dks396"},{"key":"11115_CR41","doi-asserted-by":"publisher","first-page":"e00115","DOI":"10.1128\/CMR.00115-20","volume":"34","author":"D Yahav","year":"2021","unstructured":"Yahav D, Giske Cg, Gramatniece A, Abodakpi H, Tam Vh LL. New \u03b2-lactam\u2013\u03b2-lactamase inhibitor combinations. Clin Microbiol Rev. 2021;34:e00115\u201320. https:\/\/doi.org\/10.1128\/CMR.00115-20.","journal-title":"Clin Microbiol Rev"},{"key":"11115_CR42","doi-asserted-by":"crossref","unstructured":"Balkan II, Ayg\u00fcn G, Aydin S, Mutcali SI, Kara Z, Ku\u015fkucu M et al. Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival. Int J Infect Dis [Internet]. 2014 [cited 2024 Oct 15];26. Available from: https:\/\/www.ijidonline.com\/article\/S1201-9712(14)01540-9\/fulltext","DOI":"10.1016\/j.ijid.2014.05.012"},{"key":"11115_CR43","doi-asserted-by":"crossref","unstructured":"Stewardson AJ, Marimuthu K, Sengupta S, Allignol A, El-Bouseary M, Carvalho MJ et al. Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort study. Lancet Infect Dis [Internet]. 2019 [cited 2024 Oct 15];19:601\u201310. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31047852\/","DOI":"10.1016\/S1473-3099(18)30792-8"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11115-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11115-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11115-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T09:49:02Z","timestamp":1747820942000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11115-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11115"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11115-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]},"assertion":[{"value":"25 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical standards of the Declaration of Helsinki (as revised in 2013) and the Brazilian National Health Council Resolution No. 466\/12, which regulates research involving human subjects in Brazil. The research protocol was reviewed and approved by the Research Ethics Committee of the Nursing School of Federal University of Bahia (UFBA) (CAAE 30904614.2.0000.5531; 2.170.080), the Medical Board and Ethics Committee of S\u00e3o Rafael Hospital (CAAE 79250817.4.0000.0048) and the Medical Board and Ethics Committee of the Hospital da Bahia (CAAE 30904614.2.3006.5606). Both the Medical Boards and Ethics Committee of S\u00e3o Rafael Hospital and Hospital da Bahia provided ethical clearance for conducting this study and waivered the requirement to obtain informed consent from the patients whose medical records were analyzed in this study, as it involved an internal, retrospective review of patient charts without any acquisition of identifying patient information. Permission was obtained to review patient charts. The data were accessible only to authorized members of the core study team.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests. JNR is an Editorial Board Member in BMC Infectious Diseases.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"725"}}